e-learning
resources
Virtual 2021
05.09.2021
COVID-19 and obstructive diseases: risk factors, management and long-term effects
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Clinical characteristics and outcomes in hospitalized COVID-19 patients with COPD
M. Turan (Izmir, Turkey), B. Arpinar Yigitbas (Istanbul, Turkey), P. Turan (Izmir, Turkey), A. Mirici (Canakkale, Turkey)
Source:
Virtual Congress 2021 – COVID-19 and obstructive diseases: risk factors, management and long-term effects
Session:
COVID-19 and obstructive diseases: risk factors, management and long-term effects
Session type:
E-poster
Number:
959
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Turan (Izmir, Turkey), B. Arpinar Yigitbas (Istanbul, Turkey), P. Turan (Izmir, Turkey), A. Mirici (Canakkale, Turkey). Clinical characteristics and outcomes in hospitalized COVID-19 patients with COPD. 959
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
Associations between clinical, laboratory and therapeutical parameters on admission and adverse outcomes in patients hospitalized for COPD exacerbations
Source: Annual Congress 2010 - Pharmacological modulation of biomarkers and management
Year: 2010
Clinical features and outcome of COVID-19 pneumonia in haemodialysis patients
Source: Virtual Congress 2021 – Diagnosis and management of COVID-19
Year: 2021
Sit-to-stand ability in patients hospitalised for acute exacerbation of COPD: Clinical characteristics and short-term outcomes
Source: International Congress 2015 – New insights into exercise and muscle performance
Year: 2015
Clinical features of COVID-19 pneumonia in elderly patients
Source: Virtual Congress 2021 – COVID - 19 epidemiology
Year: 2021
General characteristics in our patients with COPD
Source: Eur Respir J 2004; 24: Suppl. 48, 151s
Year: 2004
Study of clinical presentation and predictors of adverse outcome in patients admitted for acute exacerbation of COPD.
Source: International Congress 2019 – Airway disease-associated exacerbations
Year: 2019
Clinical characteristics and determinants of exacerbation in Japanese patients with COPD: Hokkaido COPD cohort study results
Source: Annual Congress 2012 - COPD exacerbation
Year: 2012
Comorbidome and short-term prognosis in hospitalised COPD patients: the ESMI study
Source: Eur Respir J 2015; 46: 850-853
Year: 2015
Clinical characteristics and outcomes of hospitalized COVID-19 pneumonia : impact of gender
Source: Virtual Congress 2021 – Clinical features and challenges of COVID-19
Year: 2021
Clinical phenotypic differences between COPD and asthma in elderly patients
Source: Eur Respir J 2004; 24: Suppl. 48, 60s
Year: 2004
Clinical features and determinants of COPD exacerbation in the Hokkaido COPD cohort study
Source: Eur Respir J 2014; 43: 1289-1297
Year: 2014
Clinical characteristics of pneumonia in the elderly
Source: Annual Congress 2010 - Treatment and risk factors in lower respiratory tract infections
Year: 2010
LATE-BREAKING ABSTRACT: Baseline demographic and clinical profile of patients with and without cardiovascular diseases in the assessment of comorbidities in COPD in european symptomatic subjects from primary care (ACCESS) study
Source: Annual Congress 2013 –A modern approach to lung diseases: from bronchi to pleura
Year: 2013
Characteristics and outcomes of asthmatic patients with COVID-19 pneumonia who require hospitalisation
Source: Eur Respir J, 56 (5) 2001875; 10.1183/13993003.01875-2020
Year: 2020
Clinical characteristics and burden of illness in a cohort of severe asthma patients
Source: International Congress 2016 – Asthma: treatment, disease control, and quality of life
Year: 2016
Clinical characteristics of 112 patients with bronchiectasis
Source: Annual Congress 2010 - Airway responsiveness, chronic cough and bronchiectasis: a modern approach
Year: 2010
Characteristics and outcome of patients admitted to intensive care with acute exacerbation of COPD
Source: Eur Respir J 2006; 28: Suppl. 50, 393s
Year: 2006
The impact of comorbidities on the short-term serious health outcomes in hospitalized COPD patients due to exacerbation
Source: Annual Congress 2013 –COPD treatment and others
Year: 2013
Clinical characteristics and treatment outcomes of tuberculosis in the elderly
Source: Annual Congress 2012 - Non-tuberculous and tuberculous mycobacterial infections: from epidemiology to clinical findings
Year: 2012
Gender differences of echocardiographic characteristics in patients with acute exacerbation of COPD
Source: International Congress 2015 – Non-inflammatory monitoring of airway diseases
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept